Rexahn Pharmaceuticals, Inc. (RNN) Announces Publication on the Anti-Tumor Activity of Novel Anticancer Compound RX-8243
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company dedicated to developing and commercializing first in class and market leading therapeutics…